6-bromo-N-(2-chlorophenyl)-2-methylimidazo[1,2-a]pyridine-3-carboxamide

ID: ALA1077741

PubChem CID: 46882745

Max Phase: Preclinical

Molecular Formula: C15H11BrClN3O

Molecular Weight: 364.63

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1nc2ccc(Br)cn2c1C(=O)Nc1ccccc1Cl

Standard InChI:  InChI=1S/C15H11BrClN3O/c1-9-14(20-8-10(16)6-7-13(20)18-9)15(21)19-12-5-3-2-4-11(12)17/h2-8H,1H3,(H,19,21)

Standard InChI Key:  ZUSNVDFABMKMFR-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 21 23  0  0  0  0  0  0  0  0999 V2000
    5.1194   -7.6791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1183   -8.5065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8331   -8.9194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8313   -7.2664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5467   -7.6755    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5515   -8.5019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3390   -8.7528    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8209   -8.0813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3312   -7.4156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3482   -6.5925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0701   -6.1931    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6414   -6.1671    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6564   -5.3422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3828   -4.9462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3982   -4.1221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6930   -3.7030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9665   -4.0996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9547   -4.9224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2341   -5.3242    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.4049   -7.2668    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    8.6459   -8.0764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  4  1  2  0
  9 10  1  0
  5  6  1  0
 10 11  2  0
 10 12  1  0
  2  3  2  0
 12 13  1  0
  3  6  1  0
 13 14  2  0
  1  2  1  0
 14 15  1  0
  5  4  1  0
 15 16  2  0
  6  7  2  0
 16 17  1  0
  7  8  1  0
 17 18  2  0
 18 13  1  0
  8  9  2  0
 18 19  1  0
  9  5  1  0
  1 20  1  0
  8 21  1  0
M  END

Associated Targets(Human)

EPHB3 Tchem Ephrin type-B receptor 3 (1881 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 364.63Molecular Weight (Monoisotopic): 362.9774AlogP: 4.31#Rotatable Bonds: 2
Polar Surface Area: 46.40Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.17CX LogP: 3.28CX LogD: 3.28
Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.74Np Likeness Score: -2.42

References

1. Qiao L, Choi S, Case A, Gainer TG, Seyb K, Glicksman MA, Lo DC, Stein RL, Cuny GD..  (2009)  Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors.,  19  (21): [PMID:19783434] [10.1016/j.bmcl.2009.09.010]

Source